The increase in pediatric myocarditis cases since August 2023 was associated with B19V infection in young children, highlighting their vulnerability.
An increase in severe pediatric myocarditis since August 2023 is associated with Parvovirus B19 infection, highlighting the specific vulnerability of young children to this pathogen.
Absolute Event Rate: 0% vs 0%
The increase in pediatric myocarditis since August 2023 was associated with B19V, more likely explained by disproportionately young current cases and young children's vulnerability than a virulent strain. Raising clinicians' awareness and proactive, interdisciplinary approaches are essential for improving prevention of B19V infection, management of myocarditis, and treatment strategies in this vulnerable cohort. (Myocarditis Registry for Children and Adolescents MYKKE; NCT02590341).
Seidel et al. (Thu,) reported a other. The increase in pediatric myocarditis cases since August 2023 was associated with B19V infection in young children, highlighting their vulnerability.